Joe Bonaccorso

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, Pennsylvania
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joe Bonaccorso:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. CHIEF COMMERCIAL OFFICER Common Stock 107K $746K $6.98 Jul 23, 2024 Direct
Verrica Pharmaceuticals Inc. CHIEF COMMERCIAL OFFICER Employee Stock Option (right to buy) 80K Mar 15, 2024 Direct

Insider Reports Filed by Joe Bonaccorso

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Jul 22, 2024 2 -$181K 4 Jul 23, 2024 CHIEF COMMERCIAL OFFICER
VRCA Verrica Pharmaceuticals Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 CHIEF COMMERCIAL OFFICER
VRCA Verrica Pharmaceuticals Inc. Nov 14, 2023 2 -$96.7K 4 Nov 16, 2023 Chief Commercial Officer
VRCA Verrica Pharmaceuticals Inc. Aug 24, 2023 1 $0 4 Aug 28, 2023 Chief Commercial Officer
VRCA Verrica Pharmaceuticals Inc. Jul 21, 2023 2 -$185K 4 Jul 25, 2023 Chief Commercial Officer
VRCA Verrica Pharmaceuticals Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Chief Commercial Officer
VRCA Verrica Pharmaceuticals Inc. Feb 24, 2022 1 $0 4 Feb 25, 2022 Chief Commercial Officer